These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 6846025

  • 1. Application of a primate model for tardive dyskinesia.
    Bárány S, Häggström JE, Gunne LM.
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):86-9. PubMed ID: 6846025
    [Abstract] [Full Text] [Related]

  • 2. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L, Casey DE, Hoffman WF, McCall AL.
    Arch Intern Med; 1993 Jun 28; 153(12):1469-75. PubMed ID: 8512437
    [Abstract] [Full Text] [Related]

  • 3. Effects of sulpiride on persistent neuroleptic-induced dyskinesia in monkeys.
    Häggström JE.
    Acta Psychiatr Scand Suppl; 1984 Jun 28; 311():103-8. PubMed ID: 6142586
    [Abstract] [Full Text] [Related]

  • 4. Sulpiride-induced tardive dystonia.
    Miller LG, Jankovic J.
    Mov Disord; 1990 Jun 28; 5(1):83-4. PubMed ID: 1967484
    [Abstract] [Full Text] [Related]

  • 5. A monkey model of tardive dyskinesia (TD): evidence that reversible TD may turn into irreversible TD.
    Kovacic B, Domino EF.
    J Clin Psychopharmacol; 1982 Oct 28; 2(5):305-7. PubMed ID: 6890075
    [Abstract] [Full Text] [Related]

  • 6. Development of acute dystonia and tardive dyskinesia in cebus monkeys.
    Bárány S, Ingvast A, Gunne LM.
    Res Commun Chem Pathol Pharmacol; 1979 Aug 28; 25(2):269-79. PubMed ID: 115074
    [Abstract] [Full Text] [Related]

  • 7. Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
    Domino EF.
    Psychopharmacology Suppl; 1985 Aug 28; 2():217-23. PubMed ID: 2860660
    [Abstract] [Full Text] [Related]

  • 8. Experimental tardive dyskinesia.
    Gunne LM, Häggström JE.
    J Clin Psychiatry; 1985 Apr 28; 46(4 Pt 2):48-50. PubMed ID: 2858481
    [Abstract] [Full Text] [Related]

  • 9. Cebus apella, a nonhuman primate highly susceptible to neuroleptic side effects, carries the GLY9 dopamine receptor D3 associated with tardive dyskinesia in humans.
    Werge T, Elbaek Z, Andersen MB, Lundbaek JA, Rasmussen HB.
    Pharmacogenomics J; 2003 Apr 28; 3(2):97-100. PubMed ID: 12746734
    [Abstract] [Full Text] [Related]

  • 10. Regional changes in 2-deoxyglucose uptake associated with neuroleptic-induced tardive dyskinesia in the Cebus monkey.
    Mitchell IJ, Crossman AR, Liminga U, Andren P, Gunne LM.
    Mov Disord; 1992 Apr 28; 7(1):32-7. PubMed ID: 1557064
    [Abstract] [Full Text] [Related]

  • 11. Acute chorea associated with metoclopramide use.
    Dubow JS, Leikin J, Rezak M.
    Am J Ther; 2006 Apr 28; 13(6):543-4. PubMed ID: 17122536
    [Abstract] [Full Text] [Related]

  • 12. Animal models of tardive dyskinesia--a review.
    Kulkarni SK, Naidu PS.
    Indian J Physiol Pharmacol; 2001 Apr 28; 45(2):148-60. PubMed ID: 11480221
    [Abstract] [Full Text] [Related]

  • 13. Haloperidol-induced tardive dyskinesia in monkeys.
    Gunne LM, Bárány S.
    Psychopharmacology (Berl); 1976 Nov 24; 50(3):237-40. PubMed ID: 826968
    [Abstract] [Full Text] [Related]

  • 14. A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia.
    Gunne LM, Bárány S.
    Psychopharmacology (Berl); 1979 Jun 21; 63(3):195-8. PubMed ID: 39307
    [Abstract] [Full Text] [Related]

  • 15. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA, Thaker GK, Moran M, Kakigi T, Gao XM.
    J Clin Psychiatry; 1994 Sep 21; 55 Suppl B():102-6. PubMed ID: 7961550
    [Abstract] [Full Text] [Related]

  • 16. Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias.
    Häggström JE, Gunne LM, Carlsson A, Wikström H.
    J Neural Transm; 1983 Sep 21; 58(3-4):135-42. PubMed ID: 6663299
    [Abstract] [Full Text] [Related]

  • 17. Life-threatening tardive dyskinesia caused by metoclopramide.
    Samie MR, Dannenhoffer MA, Rozek S.
    Mov Disord; 1987 Sep 21; 2(2):125-9. PubMed ID: 3504264
    [Abstract] [Full Text] [Related]

  • 18. Review article: metoclopramide and tardive dyskinesia.
    Rao AS, Camilleri M.
    Aliment Pharmacol Ther; 2010 Jan 21; 31(1):11-9. PubMed ID: 19886950
    [Abstract] [Full Text] [Related]

  • 19. Sulpiride in tardive dyskinesia.
    Gerlach J, Casey DE.
    Acta Psychiatr Scand Suppl; 1984 Jan 21; 311():93-102. PubMed ID: 6142590
    [Abstract] [Full Text] [Related]

  • 20. Effects of intravenous metoclopramide in 81 patients with tardive dyskinesia.
    Doongaji DR, Jeste DV, Jape NM, Sheth AS, Apte JS, Vahia VN, Desai AB, Parikh MD, Rathi LG, Ghandi MH, Parikh RM, Thatte S, Bharadwaj J.
    J Clin Psychopharmacol; 1982 Dec 21; 2(6):376-9. PubMed ID: 7174860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.